Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients
Table 1
Demographics and baseline clinical characteristics of patients hospitalized with COVID-19. Data expressed as . value less than 0.05 was considered statistically significant.
Variable
Total
No comorbidity (, % within total)
Any comorbidity (, % within total)
value
Study size
369
151 (40.9%)
218 (59.1%)
Male
272 (73.7%)
103 (37.8%)
169 (62.1%)
0.051
Female
97 (26.2%)
48 (49.4%)
49 (50.5%)
Age (in years)
≤0.001
Blood pressure-systolic (mmHg)
≤0.001
Blood pressure-diastolic (mmHg)
0.133
Pulse rate (beats/minute)
0.184
Respiratory rate (breaths/minute)
0.001
SPO2 (%)
0.005
Temperature (Fahrenheit)
0.201
Survivors
283 (76.69%)
137 (48.4%)
146 (51.5%)
≤0.001
Nonsurvivors
86 (23.30%)
14 (16.3%)
72 (83.7%)
ICU admissions
117 (31.7%)
23 (19.7%)
94 (80.3%)
≤0.001
Non-ICU admissions
252 (68.3%)
125 (49.6%)
127 (50.4%)
Length of hospital stay (in days)
≤0.001
Note: categorical variables were analyzed using Chi-square test.
